A B S T R A C T After oral administration of [2,4-3H]-cholyl [S]taurine to eight healthy subjects with indwelling nasoduodenal tubes, the specific activity of the cholyl and taurine moieties and the distribution of radioactivity in biliary bile acid and urinary metabolites, as well as total urinary and fecal 'S and 'H, vere measured at intervals for 4-8 days. Similar measurements were made after ["S]taurine was given orally or intravenously or instilled into the distal intestine. The daily fractional turnover rate of the taurine moiety of cholyltaurine was low and similar to that of the cholyl moiety, indicating that deconjugation occurring during enterohepatic cycling was less than half that previously observed for glycine-conjugated bile acids. Some of the cholyl moiety was absorbed but, since reconjugation occurred predominantly with glycine, little reincorporation into the cholyltaurine pool was observed. Some of the taurine moiety was also absorbed intact but entered large taurine pools, and little reincorporation into the cholyltaurine pool was seen. Oral administration of taurine expanded the cholyltaurine pool and induced a decrease in the fractional turnover rate of the cholyl moiety of cholyltaurine, interpreted to indicate a greater reincorporation of the cholyl moiety because of increased reconjugation with taurine. Taurine moiety not absorbed as taurine appeared to be absorbed largely as sulfate which, like taurine, entered large endogenous pools. Little fecal excretion of 'S occurred. 'S was excreted in urine as taurine and sulfate, and excretion in the first 24 h (as per- 
INTRODUCTION
We have previously defined the metabolism of the steroid and amino acid moieties of glycine-conjugated bile acids (1, 2) in man. About 18% of the pool of glycineconjugated bile acids is deconjugated in each enterohepatic cycle and about two-thirds of the steroid moiety liberated is conserved and reconjugated, predominantly with glycine in the liver. Consequently, the synthesis of bile acid glycine is about three times that of the steroid moiety. The glycine liberated from cholyl [1-14C] glycine in the gastrointestinal tract is either converted to 4CO2 in the intestinal lumen or, if absorbed, enters the large body pool of glycine; virtually none of the glycine liberated in the intestinal lumen can be detected in the glycine used for conjugation with free bile acids in the liver.
In man, about one-quarter of the biliary bile acids are conjugated with taurine (3). Garbutt, Wilkins, Lack, and Tyor (4) administered [24--4C] cholyltaurine and calculated its half-life as well as its rate of 7-dehydroxylation after bacterial deconjugation, but they gave no information on the taurine moiety. In this paper we describe the synthesis of [2,4-3H] cholyl['S]taurine and its administration to eight healthy subjects in order to characterize simultaneously the metabolism of the cholyl and taurine moieties of the bile acid. In addition, we carried out limited experiments on the metabolism of [3S] taurine in order to interpret our results.
METHODS
The metabolism of cholyltaurine was studied in eight subjects who were ingesting a normal diet and in two subjects whose taurine intakes were varied. In three additional subjects, [MS] taurine was given orally (two subjects) or intravenously (one subject). In three subjects, [3S]taurine was instilled via a tube placed in the distal ileum or the cecum.
Materials. [2,4-3H] cholic acid was prepared from methyl 3-keto-7a,12a-dihydroxy-5p-cholanoate (5) and conjugated with taurine (6) . The final specific activity was approxi- Reference compounds were chromatographed simultaneously and radioactivity was assigned to (a) cholyltaurine, (b) deoxycholyl-or chenodeoxycholyltaurine, (c) cholylglycine, and (d) deoxycholylglycine.
Bile acid kinetics were calculated according to a firstorder kinetic model (9) . The equation for the specific activity decay curve of [2,4-8H] cholyltaurine and cholyl-[3S] taurine was calculated by least-squares; the linearity of the logarithmic specific activity decay was indicated by a correlation coefficient of greater than 0.97 for all studies. [2, cholyltaurine specific activity at time 0 was obtained by extrapolation and the dose of radioactivity administered was divided by this value to give the pool size. The slope of the logarithmic specific activity decay curve is the rate constant or fractional turnover (days-1). The daily synthesis of the cholyl and taurine moieties of cholyltaurine was obtained by multiplying the pool (millimoles) by the daily fractional turnover.
Two 4-day stool samples were collected from each subject. After homogenization, a 1 g sample was dried and combusted in oxygen to convert 3H radioactivity to [3H]-H20 (Packard oxidizer, model 305, Packard Instrument Co., Inc., Downers Grove, Ill.). A second 1 g sample was mixed with 2 ml of 70% perchloric acid-10 N sulfuric acid (1: 10 vol/vol) and heated in a liquid scintillation vial on a hot plate at low heat until the solution was colorless and all solid matter was digested (this required at least 48 h). 1-2 ml of water was then added and heating was continued until the water had evaporated, thereby removing 'H as Urine samples were collected daily. 3H in urine water was determined by distilling the urine from a liquid scintillation vial placed in the heated combustion chamber of the Packard oxidizer and counting the [3H]H20 in the distillate. The residue, which was found to contain only 'S, was then digested with the perchloric-sulfuric acid mixture and counted as described.
Taurine concentration in plasma of two subjects (CT, and CT2) and urine of all subjects was determined by using a Beckman 120C automatic amino acid analyzer (Beckman Instruments, Inc., Fullerton, Calif.). Plasma was prepared for analysis by precipitating the protein with an equal volume of 6%o sulfosalicylic acid and centrifugation; urine was prepared for analysis as previously described (10) .
[3S]sulfate was determined by counting samples of urine or plasma, as prepared for amino acid analysis, before and after precipitation of sulfate by the addition of excess barium chloride solution (in the presence of added carrier sulfate). In each case, 1 ml of aqueous solution was dissolved in 10 ml of Triton X-100-toluene phosphor (11) and counted for 100 min in a Packard 3320 liquid scintillation counter.
Radioactivity which remained after sulfate precipitation was assumed to be taurine on the basis of the following observations. Urine and plasma samples (sometimes concentrated as described by Wainer, King, Goodman, and Thomas [12] ) analyzed with a flow-cell scintillation countei coupled to an amino acid analyzer (11) showed two peaks corresponding to a frontal elution and to the position of authentic taurine. After precipitation of sulfate with barium chloride, the frontal elution peak almost completely disappeared, the radioactivity remaining in this position representing less than 0.2%o of the total in the sample for all samples analyzed. The area of the taurine peak was un-changed by this procedure, confirming that no taurine was precipitated by the BaCli. The diet, then on a diet supplying 9.0 g of taurine per day (beginning 7 days before the study and lasting for a total of 12 days), and then on a taurine-free diet. The second subject was studied twice-first on a taurine-free diet and then on a diet supplying 4.5 g of taurine per day (beginning 7 days before the study and lasting a total of 14 days). Pool size and kinetics were determined by the methods described above. In these subjects, it was possible to identify a 'S component in urine which was not sulfate or taurine. The bulk of this radioactivity, which composed < 5% of urinary 'S radioactivity, chromatographed with authentic isethionic acid, as described by Goodman, Wainer, King, and Thomas (13 
RESULTS
Fractional turnover and synthesis rates of cholyl and taurine moieties of cholyltaurine. The mean daily fractional turnover of the taurine moiety was not significantly different from that of the cholyl moiety (Table I ).
The daily syntheses of the cholyl and taurine moieties were not significantly different since the daily fractional turnover rates of these moieties were similar.
Distribution of radioactivity in biliary bile acids.
There was a progressive decrease of 'H in cholyltaurine and a reciprocal increase of 'H in cholylglycine and Time,days FIGURE 1 Time-course of distribution of 8H among conjugated bile acid classes, shown as means. Classes were separated by thin-layer chromatography. deoxycholylglycine, as well as deoxycholyltaurine, during the 4 days of the study (Fig. 1) . After 4 days, the mean (±SE) percentages of 8H in cholyltaurine and cholylglycine were equal (37.0±5.0%). The distribution of 8H in the biliary bile acids varied considerably among the subjects. In two subjects (CT1 and CT2) who had the highest fractional turnover rate of the cholyl moiety, nearly half of the 'H in the biliary bile acids was in cholylglycine after 4 days whereas in subjects CT4 and CT6, only 25 and 21% of the 3H was in this fraction. 'S was present exclusively in cholyltaurine throughout the experiment and did not appear in deoxycholyl-or chenodeoxycholyltaurine.
Effect of expansion of cholyltaurine pool on kinctics of cholyltaurine. Since taurine supplementation is known to increase the proportion of bile acids which are conjugated with taurine (14) , it should increase the cholyl- taurine pool. The appearance of 'H in cholylglycine indicated that, after liberation in the intestinal lumen, the cholyl moiety of cholyltaurine was absorbed and reconjugated predominantly with glycine. Therefore, if the pattern of conjugation could be changed from predominantly glycine to predominantly taurine, any cholyl moiety which was reabsorbed should now be reconjugated predominantly with taurine. Since the decrease of the specific activity of the cholyl moiety of cholyltaurine is caused by loss of the cholyl moiety from the pool, decreased loss into cholylglycine should be associated with a slower fractional turnover rate of the cholyl moiety of cholyltaurine. Table II shows that taurine supplementation caused an expansion of the cholyltaurine pool and a decrease in the fractional turnover rate of the cholyl moiety of cholyltaurine in two subjects. Fate of "'S. 'S was excreted chiefly in urine in 6 days with little appearing in stool in 8 days (Table III) . After 8 days, about half of the administered radioactivity was still present in the body and was being excreted slowly (Fig. 2) . 'S recovered in urine was predominantly in sulfate and taurine (Table IV) . In two of the four subjects followed for 2 wk, the percentage of urinary radioactivity present as sulfate tended to decrease with time, with a reciprocal increase in the percentage present as taurine. In these subjects, a sizable fraction of liberated taurine appeared to have been absorbed as such after bacterial deconjugation.
When taurine was instilled directly into the intestine, '5S could be shown to be present in ['S]taurine in plasma in two of three subjects, indicating that taurine can be absorbed from the distal intestinal lumen. Specific activity values were low and less than 1% of the absorbed taurine appeared in cholyltaurine (Table V) . The percentage of urinary activity found in urinary sulfate after administration of [3S]taurine was influenced by the route by which the ["S]taurine was administered (Table VI) . It was lowest when the taurine was administered parenterally and not exposed to intestinal bacteria, higher when the taurine was given orally, still higher when the taurine was exposed to ileal bacteria, and highest when the taurine was exposed to colonic bacteria. The daily fractional turnover rate and the recovery of 'S in urine in 24 h (chiefly as sulfate) correlated highly (r = 0.93) (Fig. 3) .
Fate of 'H. 'H was recovered from feces and urine (Table III) . Urinary 'H was present entirely as ['H]-H20 since all radioactivity appeared in the distillate, consistent with the view that the cholyl moiety is excreted entirely by the fecal route. The ['H]H20 is considered to originate from bacterial liberation of 'H, presumably by bacterial desaturation (15) and is thus an artifact resulting from the use of a bile acid containing 'H at a position on the steroid ring accessible to bacterial enzymes. The percentage of administered 'H absorbed from the distal intestine and entering the pool of body water was estimated by multiplying the maximal specific activity of water during the first 6 days after administration of [2,4-'H] cholyltaurine by the pool of body water (body weight times 0.6 [16] ) and dividing this product by the administered dose. The data were normalized for a (Table  VII) was greater than the percentage of administered dose recovered in the urine in 14 days (5.7-14.2%), presumably reflecting the excretion rate of body water of which only about 2% is excreted per day in the urine (16) .
DISCUSSION
Deconjugation during enterohepatic cycling. The low rates of incorporation, into cholyltaurine, of intravenously or orally administered taurine suggest that little reincorporation of taurine occurred after deconjugation. 
(4).
The ratio of glycine-conjugated bile acids to taurineconjugated bile acid in bile is about 3, but since there is less deconjugation of taurine-conjugated bile acids during enterohepatic cycling, the ratio of rates of conjugation is probably considerably greater than 3 even in health.
For cholylglycine, about 3 mmol is used daily for conjugation (1); for cholyltaurine, it is about 0.4 mmol (Table I) . Thus, the ratio of conjugation rates is about 8, and about 10-15% of the cholyl moiety should have been reincorporated into cholyltaurine. Feeding of taurine is thought to increase the taurine pool, increase conjugation of bile acids with taurine (20, 21) , and, as shown in these studies, enlarge the cholyltaurine pool. Under these conditions, greater reincorporation of the cholyl moiety into cholyltaurine should occur, evidenced by slower turnover rate of the cholyl moiety relative to taurine. The low degree of incorporation, into cholyltaurine, of radioactivity from intravenously administered [5S]-taurine resulted from rapid dilution by large endogenous pools. Similar dilution is assumed to have occurred when taurine was given orally, since taurine is well absorbed when ingested by mouth (22 pound in the urine that was labeled with 'S. The high correlation between the fractional turnover rate of taurine and the percentage of administered 'S recovered in the urine in the first 24 h is thus dependent on bacterial conversion of liberated free taurine to sulfate which, in turn, is absorbed and in part rapidly excreted. The absence of 'S in the taurine-conjugated dilldroxv bile acid fraction indicates that, in these subjects, no detectable dehydroxylation without deconjugation occurred. Cholylglycine has been showNn to be dehydroxylated without deconjugation both in vitro and in vivo in some instances (1) .
Fate of cholyl label. Body water became rapidly labeled with 'H. We suspect that 3H release was related to bacterial desaturation (15) of 3-keto bile acids which have been detected in the feces (28) . Furthermnore, at the pH of the colonic lumen, 'H in positions 2 and 4 of a 3-keto bile acid might exchange nonenzymatically with water, leading to excretion of 'H in the urine. However, release of 'H as [3H]H20 followed by equilibration with body water would not materially affect the calculation of pool size and turnover rate, provided the bile acids involved had already been lost from the enterollepatic circulation. Indeed, the turnover rates of 'H-labeled bile acids reported previously by us (1, 2) agree well with those found by Vlahcevic, Miller, Farrar, and Swell (29) using "4C-labeled acids. Evidence that bile acid kinetics may be determined validly by using 2,4-3H-labeled bile acids has previously been presented for two healthy subjects (5) . However, additional confirmation of this thesis would now appear warranted.
Mfetabolism of steroid and amino acid moieties of conjugated cholyl bile acids in man. The present study as well as that previously reported for cholylglycine (1) permit some general conclusions. For both conjugated trihydroxy bile acids, the majority of secreted bile acid is absorbed without deconjugation, although cholylglycine is hydrolyzed more than twice as rapidly as cholyltaurine. More than half of the liberated cholyl moiety is conserved and is reconjugated with glycine or taurine, the idea of deconjugation and reconjugation during enterohepatic cycling first being suggested by Norman (30) 
